These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 18543809)

  • 41. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How much cash does your company need?
    Passov R
    Harv Bus Rev; 2003 Nov; 81(11):119-22, 124-6, 128, 140. PubMed ID: 14619157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The curse of the superstar CEO.
    Khurana R
    Harv Bus Rev; 2002 Sep; 80(9):60-6, 125. PubMed ID: 12227147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Public administration and R&D localisation by pharmaceutical and biotech companies: a theoretical framework and the Italian case-study.
    Jommi C; Paruzzolo S
    Health Policy; 2007 Apr; 81(1):117-30. PubMed ID: 16824641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organizing for innovation: towards successful translational research.
    West W; Nightingale P
    Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Building breakthrough businesses within established organizations.
    Govindarajan V; Trimble C
    Harv Bus Rev; 2005 May; 83(5):58-68, 152. PubMed ID: 15929404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Driving change: an interview with Ford Motor Company's Jacques Nasser. Interview by Suzy Wetlaufer.
    Nasser J
    Harv Bus Rev; 1999; 77(2):76-88, 186. PubMed ID: 10387773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spinning out a star.
    Lord MD; Mandel SW; Wager JD
    Harv Bus Rev; 2002 Jun; 80(6):115-21, 154. PubMed ID: 12048993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.
    Janero DR
    Expert Opin Drug Discov; 2014 Nov; 9(11):1265-79. PubMed ID: 25162124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Process R&D under the magnifying glass: organization, business model, challenges, and scientific context.
    Federsel HJ
    Bioorg Med Chem; 2010 Aug; 18(16):5775-94. PubMed ID: 20621486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A call for sharing: adapting pharmaceutical research to new realities.
    Munos BH; Chin WW
    Sci Transl Med; 2009 Dec; 1(9):9cm8. PubMed ID: 20368187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Make your company a talent factory.
    Ready DA; Conger JA
    Harv Bus Rev; 2007 Jun; 85(6):68-77, 141. PubMed ID: 17580649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What is the most important approach in current drug discovery: doing the right things or doing things right?
    Elebring T; Gill A; Plowright AT
    Drug Discov Today; 2012 Nov; 17(21-22):1166-9. PubMed ID: 22569181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cultural change--empowerment at Sweetheart Cup Company, Inc., Bakery Division.
    Altomonte W; Mooney W; Sheldon DH
    Hosp Mater Manage Q; 1999 Aug; 21(1):53-8. PubMed ID: 10662450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management consulting for scientists.
    Kulkarni S
    Nat Biotechnol; 2007 Dec; 25(12):1489-90. PubMed ID: 18066046
    [No Abstract]   [Full Text] [Related]  

  • 58. [Biopharmaceutical industry's commitment to innovation and to the future of health care].
    Marini G
    Recenti Prog Med; 2006 Nov; 97(11):626-33. PubMed ID: 17252719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Magnet Model as a framework for excellence.
    Morgan SH
    J Nurs Care Qual; 2009; 24(2):105-8. PubMed ID: 19287247
    [No Abstract]   [Full Text] [Related]  

  • 60. What is it like to work for a pharmaceutical company? Interview by Barbara J. Linney.
    Kaufman EA
    Physician Exec; 2001; 27(2):80-3. PubMed ID: 11291228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.